Effective removal of colistin methanesulphonate and formed colistin during intermittent haemodialysis in a patient infected by polymyxin-only-susceptible Pseudomonas aeruginosa

Sonia Luque, Luisa Sorli, Jian Li, Silvia Collado, Francesc Barbosa, Nuria Berenguer, Juan Pablo Horcajada, Santiago Grau

Research output: Contribution to journalArticleResearchpeer-review

11 Citations (Scopus)

Abstract

Colistin use has reemerged for the treatment of infections caused by multidrug-resistant Gram-negative bacteria. However, the information on its pharmacokinetics is limited, especially in patients with end-stage renal disease, in which dosage adjustments are contradictory, and evidences the need to investigate the removal of colistin through renal replacement therapies like haemodialysis. This case study showed efficient removal of colistin methanesulphonate and formed colistin during intermittent haemodialysis in a patient infected by polymyxin-only-susceptible Pseudomonas aeruginosa. These results suggest the importance to monitor colistin plasma concentrations in these patients to minimize treatment failure due to suboptimal exposure to antibacterial colistin. © 2014 Edizioni Scientifiche per l'Informazione su Farmaci e Terapia.
Original languageEnglish
Pages (from-to)122-124
JournalJournal of Chemotherapy
Volume26
Issue number2
DOIs
Publication statusPublished - 1 Jan 2014

Keywords

  • Colistin
  • Haemodialysis
  • Pharmacokinetics
  • Pseudomonas aeruginosa
  • Renal insufficiency

Fingerprint Dive into the research topics of 'Effective removal of colistin methanesulphonate and formed colistin during intermittent haemodialysis in a patient infected by polymyxin-only-susceptible Pseudomonas aeruginosa'. Together they form a unique fingerprint.

Cite this